ArticleCancers2022

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients.

Christian M Tegeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.